Tilyn DiGiacomo

1. Antipsychotics and obsessive–compulsive disorder/obsessive–compulsive symptoms: A pharmacovigilance study of the FDA adverse event reporting system
   2023/05/17 by Bradley G. Burk, Tilyn DiGiacomo, Shea Polancich +3 · 10 citations
   Pharmacology, Toxicology and Pharmaceutics · Psychology · Medicine · #Pharmacovigilance and Adverse Drug Reactions #Obsessive-Compulsive Spectrum Disorders #Schizophrenia research and treatment